<ul data-eligibleForWebStory="false"><li>Apple is appealing an import ban on certain Apple Watch models with blood oxygen monitoring capabilities.</li><li>The ban was imposed by the U.S. International Trade Commission in 2023 due to a patent dispute with medical technology firm Masimo.</li><li>Apple argues that the ban was based on a patent dispute involving an undeveloped competing product from Masimo.</li><li>The case is currently under consideration by the U.S. federal appeals court, with a ruling expected later this year.</li></ul>

Apple Appeals US Ban on Apple Watch Blood Oxygen Feature

Discover more